Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups
Patents for C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
10/2005
10/12/2005CN1681805A Novel imidazole compounds as transforming growth factor (TGF) inhibitors
10/12/2005CN1681792A 9-cyano-substituted perylene-3, 4-dicarboxylic acid monoimides
10/12/2005CN1680385A Separation and extraction of icariin A
10/12/2005CN1680381A Preparation of S-tricyctic lactone
10/12/2005CN1680373A Double piperazine quaternary ammonium salt compound with analgetic function
10/12/2005CN1680330A Preparation of (R)-(-)-apomorphine
10/12/2005CN1680329A Preparation of pyridine derivative
10/12/2005CN1680325A Preparation of pyridine derivatives
10/06/2005WO2005092895A2 Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as orl1-receptor antagonists
10/06/2005WO2005092858A2 Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as orl1-receptor antagonist
10/06/2005WO2005092840A1 Formamide derivatives useful as adrenoceptor
10/06/2005US20050222200 4-(2,2-dichloro)-N-(quinolin-3-yl)benzamide; (1R,2R)2-methyl-N-(quinolin-3-yl)-4-(2-(trifluoromethyl)cyclopropyl)benzamide; inflammation-related conditions in mammals, arthritis, Parkinson's/Alzheimer's diseases, stroke, asthma; acute/chronic or neuropathic pain; VR1 agonist/antagonist
10/06/2005US20050222190 1,4-bis-N-oxide azaanthracenediones and the use thereof
10/06/2005CA2563164A1 Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as orl1-receptor antagonists
10/06/2005CA2561488A1 Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as orl1-receptor antagonists
10/05/2005EP1581487A2 Methods and compounds producing dipeptidyl peptidase iv inhibitors and intermediates thereof
10/05/2005EP1581478A1 Dhodh-inhibitors and method for their identification
10/05/2005EP1581477A1 Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
10/05/2005CN1678591A New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture
10/05/2005CN1678303A Keto cannabinoids with therapeutic indications
10/04/2005US6951938 Aryl fused azapolycyclic compounds
09/2005
09/29/2005WO2005090311A1 Novel heterocyclyl-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
09/29/2005WO2005090310A2 Process for preparing cyclohexanediacetic acid monoamide
09/29/2005WO2005089294A2 Synthesis of indenoisoquinoliniums and methods of use
09/29/2005WO2005089094A2 Materials and methods for the preparation of anisotropically-ordered solids
09/29/2005WO2005025507A3 Dihydropyridine compounds for treating or preventing metabolic disorders
09/29/2005WO2005009398A3 Tetracyclic benzamide derivatives and methods of use thereof
09/29/2005US20050215799 reacting aryl/heteroaryl triflate/halide with carbon monoxide and N-hydroxysuccinimide in solvent in presence of palladium catalyst and base
09/29/2005US20050215794 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency; forming a carbon-carbon bond between a reactant comprising a nucleophilic carbon atom, e.g., enolate or malonate anion, and activated carbon of an aryl, heteroaryl, or vinyl halide or sulfonate
09/29/2005US20050215630 3-Phenyl-2-arylalkylthiopropionic acid derivatives as selective agonists of ppar-alpha
09/29/2005US20050215590 Formamide derivatives for the treatment of diseases
09/29/2005US20050215579 consisting of lung, renal, prostate, uterine, melanoma and breast tumors; cyclodextrin inclusion compounds aid solubility
09/29/2005CA2559310A1 7h-8,9-dihydro-pyrano (2,3-c) imidazo (1,2a) pyridine derivatives and their use as gastric acid secretion inhibitors
09/29/2005CA2559196A1 Novel dichloro-phenyl-pyrido [2,3-d] pyrimidine derivates, their manufacture and use as pharmaceutical agents
09/29/2005CA2557730A1 Novel heterocyclyl-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
09/28/2005EP1578748A1 Tetrahydro-4h-pyrido [1, 2-a] pyrimidines and related compounds useful as hiv integrase inhibitors
09/28/2005EP1578741A1 Aromatic compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
09/28/2005EP1578728A1 5-aminophenanthridine derivatives as npy-5 antagonists
09/28/2005CN1675218A Novel tricyclic spiropiperidines or spiropyrrolidines
09/28/2005CN1674895A Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
09/28/2005CN1220681C Indole derivatives as XA factor inhibitors
09/27/2005US6949561 polycyclic compound comprises sulphamate group attached to one of the ring components, wherein ring is naphtho(2,1-f)quinoline
09/22/2005WO2005087745A1 Novel amido-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
09/22/2005WO2005087744A1 Novel thio-containing hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
09/22/2005US20050209273 Neuroprotectants, analgesics or anticonvulsants
09/22/2005CA2558391A1 Novel amido-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
09/22/2005CA2558390A1 Novel thio-containing hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
09/22/2005CA2557904A1 Hiv integrase inhibitors
09/15/2005WO2005085203A1 Novel difluoroethoxy-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
09/15/2005WO2005084674A1 Amorphous form of desloratadine and a process for the preparation thereof
09/15/2005WO2005084104A2 Novel isoamido-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
09/15/2005WO2005051300A3 Bicyclic inhibitors of mek and methods of use thereof
09/15/2005WO2005037832B1 Azabicycyclic compounds for relieving pain and treating central nervous system disorders
09/15/2005US20050203126 Inhibitors of basic fibroblast growth factors (FGFs); treating cancer, rheumatoid arthritis, inflammatory bowel disease, cardiovascular disorders, diabetic retinopathy, achondroplasia, hypochondoplasia, or thanathophoric dysplasia
09/15/2005US20050203125 Treating pseudobulbar affect or emotional lability; nervous system, brain, and neurodegenerative disorders; analgesics; neuropathic pain; dextromethorphan hydrobromide and quinidine sulfate
09/15/2005US20050203119 Dihydropyridine compounds for treating or preventing metabolic disorders
09/15/2005CA2558532A1 Novel difluoroethoxy-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
09/15/2005CA2558375A1 Novel isoamido-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
09/14/2005EP1574500A1 Quinoline derivative as diagnostic probe for disease with tau protein accumulation
09/14/2005EP1572696A1 Process for the direct preparation of 5-alkoxy and 5-acyloxy analogues of campthothecins or mappicene ketones
09/14/2005EP1572113A2 Calcium receptor modulating compound and use thereof
09/14/2005CN1668608A Heterodiamondoids
09/14/2005CN1668300A Spirocyclic piperidines as MCH1 antagonists and uses thereof
09/09/2005WO2005082860A1 Tetracyclines and their use as calpain inhibitors
09/09/2005WO2005082856A2 Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors
09/09/2005WO2005082368A1 Isoquinoline derivatives and methods of use thereof
09/09/2005WO2005082079A2 Tetracyclic lactam derivatives and uses thereof
09/09/2005CA2557547A1 Isoquinoline derivatives and methods of use thereof
09/09/2005CA2556738A1 Tetracyclic lactam derivatives and uses thereof
09/08/2005US20050197361 Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors
09/07/2005EP1571146A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof
09/07/2005EP1569932A1 Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2
09/07/2005EP1495023B1 Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same
09/07/2005EP1042295B1 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents
09/07/2005CN1665809A Azaindoles
09/07/2005CN1665780A Tricyclic steroid hormone nuclear receptor modulators
09/07/2005CN1217937C Synthesis of intermediates useful in preparing tricyclic compounds
09/01/2005WO2005080322A1 Fluorene derivative
09/01/2005CA2537079A1 Fluorene derivative
08/2005
08/31/2005EP1567502A1 Substituted dihydrophenanthridinesul fonamides
08/31/2005EP1390366B1 The citrate salt of 5,8,14,-triazatetracyclo(10.3.1.02,11.04,9)-hexadeca-2(11),3,5,7,9-pentaene
08/31/2005CN1662504A 2, 5-disubstituted 3-mercaptopentanoic acid
08/31/2005CN1660814A (1R, 2R) or (1S, 2S)-1-(4'-substitute-1'8'-naphthoyl imdo group)-2-amino cyclohexane, preparation and application
08/31/2005CN1216604C Hexahydroindenopyridine compounds having antispermatogenic activity
08/30/2005US6936325 Optical recording medium
08/25/2005WO2005077906A1 Novel guanidinyl-substituted hydroxy-6-phenylphenenthridines as effective phosphodiesterase (pde) 4 inhibitors
08/25/2005WO2005076815A2 PERYLENE n-TYPE SEMICONDUCTORS AND RELATED DEVICES
08/25/2005US20050187110 Novel herbicides
08/25/2005DE102004006142A1 Neutrale und kationische Naphthalinderivate und diese Verbindungen enthaltende Färbemittel für Keratinfasern Neutral and cationic naphthalene derivatives and compositions containing these compounds stains for keratin fibers
08/25/2005DE102004006141A1 Aufhellende direktziehende Farbstoffe für Keratinfasern und diese Verbindungen enthaltende Färbemittel Brightening direct dyes for keratin fibers containing these compounds and dyes
08/25/2005CA2556086A1 Novel guanidinyl-substituted hydroxy-6-phenylphenenthridines as effective phosphodiesterase (pde) 4 inhibitors
08/25/2005CA2555827A1 Tricyclic imidazopyridines and intermediates for the synthesis thereof
08/25/2005CA2554302A1 Perylene n-type semiconductors and related devices
08/24/2005EP1565464A1 4-oxo-1-(3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitors
08/24/2005EP1565444A1 Sinomenine and sinomenine compounds, synthesis and use
08/24/2005EP1392307B1 Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene
08/24/2005EP1019075B1 Beta 2-adrenergic receptor agonists
08/24/2005CN1659640A Optical data carrier comprising a cationic aminoheterocyclic dye as light-absorbent compound in the information layer
08/24/2005CN1658724A Luminescent element material and luminescent element comprising the same
08/18/2005WO2005075574A1 Neutral and cationic naphthalene derivatives and dyes containing said compounds for dyeing keratin fibers
1 ... 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... 110